News

Instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.

Thermo has purchased Ionalytics Corporation a developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery.

Thermo has purchased Ionalytics Corporation a developer of a dynamic ion filtering device used with mass spectrometers in bioanalysis, proteomics and drug discovery.

Tripos' LeadDiscovery program is designed to develop leads for its pharmaceutical and biotechnology customers.

Xenocs has recently introduced the FOX2D CU 25_25P multilayer optics dedicated to the analysis of small protein crystals.

Bruker takes the step of registering its autoflex II systems as medical devices in the Republic of Korea.

Sareum to provide protein structure determination capabilities to accelerate drug discovery research at Almirall

Using Selerity's Polaratherm, Craft Technologies has conducted experiments to separate retinol and retinyl esters, carotenoids, and tocopherols

The Life Sciences R&D Division of TCS will work on a target protein identified by Congenia as a key protein involved in several age-related diseases.

Cell Signaling Technology, Inc. (CST) has announced an agreement with Novartis under which a pilot study was performed using CST's PhosphoScan™ technology to identify phosphorylation sites and prospective biomarkers of protein kinase targets.

Qiagen has entered into an agreement to acquire key assets of LumiCyte, Inc. (LCI). LC has developed and recently initiated marketing of the products based on its STS- (Surface Tension Segmented) Biochip™ sample preparation solution for MALDI Mass Spectrometry.